Meagan L. Adamsick

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

Natalie J. Atallah, Hailey M. Warren, Matthew B. Roberts et al. · PLoS ONE · 2022 · 40 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +14

Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience

Lauren E. Brownell, Meagan L. Adamsick, Erin K McCreary et al. · Drugs - Real World Outcomes · 2020 · 30 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +14

Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro‐jejunum tube: A case report

Meagan L. Adamsick, Ramy H. Elshaboury, Thais Gift et al. · Transplant Infectious Disease · 2019 · 13 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period

Ramy H. Elshaboury, Miranda Monk, Lisa M. Bebell et al. · Therapeutic Advances in Infectious Disease · 2021 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13